deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01315314

Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction

Effects of Neutral pH and Low Glucose Degradation Product-containing Peritoneal Dialysis Fluid on Systemic Markers of Inflammation and Endothelial Dysfunction: a Randomized, Controlled 1-year Follow-up Study

Sponsor: Fresenius Medical Care Korea

Conditions Disorders Associated With Peritoneal Dialysis Kidney Failure, Chronic
Interventions Balance, Fresenius Medical Care, Germany
Updated 8 times since 2017 Last updated: Mar 16, 2011 Started: Oct 31, 2005 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Disorders Associated With Peritoneal Dialysis and Kidney Failure, Chronic and is currently completed. Fresenius Medical Care Korea leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotCompleted~Oct 2019 – ~Feb 2020 · 4 months · monthly snapshotCompleted~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 3 earlier versions

  1. Oct 2019 — Feb 2020 [monthly]

    Completed PHASE4

  2. Jun 2018 — Oct 2019 [monthly]

    Completed PHASE4

  3. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fresenius Medical Care Korea
  • Kyungpook National University Hospital
  • Ministry of Health & Welfare, Korea
Data source: Kyungpook National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations